We’re excited to announce that Enzo Biochem has been acquired by Battery Ventures, a technology-focused investment firm with deep expertise in both the technology and life sciences sectors. Enzo is now operating as a private company, enabling an enhanced focus and flexibility in serving our customers worldwide.
This strategic move marks a new chapter for Enzo — one that strengthens our market position, fuels innovation, and ensures continued excellence in the quality products and services our customers have come to expect from us.
Veteran life science executive Jason Apter will lead Enzo as CEO. Mr. Apter previously served as CEO of Sannova Analytical, an organization offering bioanalytical and analytical testing services to pharmaceutical and biotech companies, as well as serving in senior leadership roles at MilliporeSigma and Johnson Matthey.
Your Questions Answered
- Who is Battery Ventures?
Known for its strategic investments and commitment to fostering innovation, Battery Ventures plays a vital role in shaping the future of technology. Battery Ventures supports life science companies by investing in industrial technology and life science tools. - What does this acquisition mean for me as a customer?
Your relationship with Enzo Life Sciences remains unchanged. You’ll continue to receive the same high-quality products and services you’ve come to expect. - Will there be any changes to existing contracts or agreements?
No changes. All current partnerships, contracts, and service agreements will continue without modification or interruption. - Is the product portfolio still available?
Yes! Our full product portfolio remains available, including reagents for genomics, proteomics, and cell biology research. - Will Enzo’s entities names change?
No. The Enzo companies remain the same so you don’t need to create a new supplier in your system. - Will technical support and global operations be affected?
Not at all. Our US and European operations and technical support teams are still here to serve you—just as they always have. - What are the benefits of this acquisition?
This merger enhances Enzo’s ability to innovate, grow, and better serve our customers while maintaining operational continuity and improvement. - Click link for full press release: Battery Ventures Completes Take-Private of Enzo Biochem
Thank you for your continued business and trust. We deeply appreciate your ongoing partnership, and we’re excited to continue to serve you under the new leadership of Battery Ventures.